4D Molecular Therapeutics (NASDAQ:FDMT) Insider Sells $19,947.00 in Stock
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) insider Scott Bizily sold 1,635 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $12.20, for a total value of $19,947.00. Following the completion of the transaction, the insider owned 8,617 shares […]
Neumora Therapeutics (NASDAQ:NMRA) Insider Daljit Singh Aurora Sells 31,000 Shares of Stock
Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) insider Daljit Singh Aurora sold 31,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 19th. The shares were sold at an average price of $1.65, for a total value of $51,150.00. Following the completion of the sale, the insider directly owned 48,750 […]
Mineralys Therapeutics (NASDAQ:MLYS) Insider Sells $58,785.30 in Stock
Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Get Free Report) insider David Malcom Rodman sold 2,170 shares of the business’s stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $27.09, for a total value of $58,785.30. Following the completion of the transaction, the insider directly owned 51,384 shares of […]
Zevra Therapeutics (NASDAQ:ZVRA) Director Sells $138,375.00 in Stock
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Free Report) Director Corey Michael Watton sold 12,300 shares of the stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $11.25, for a total value of $138,375.00. Following the sale, the director owned 1,800 shares of the company’s stock, valued at […]
Insider Selling: Entrada Therapeutics (NASDAQ:TRDA) Director Sells $647,108.00 in Stock
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) Director Kush Parmar sold 92,444 shares of the company’s stock in a transaction on Monday, August 10th. The stock was sold at an average price of $7.00, for a total value of $647,108.00. Following the transaction, the director owned 2,691,337 shares of the company’s stock, valued at […]
Entrada Therapeutics (NASDAQ:TRDA) Major Shareholder Sells $358,371.45 in Stock
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) major shareholder Ventures L.P. 5Am sold 52,317 shares of the company’s stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $6.85, for a total value of $358,371.45. Following the transaction, the insider directly owned 2,783,781 shares of […]
last updated on 20 Aug 13:18